Drug Topics
JANUARY 9, 2024
In August, the FDA issued a 1-year stabilization policy on the final enhanced drug distribution security requirements under the DSCSA. What exactly does that mean for pharmacists?
Pharmacy Times
JANUARY 9, 2024
Most important of all, we gained a new level of empathy and understanding for patients diagnosed with diabetes whose diagnosis requires that they are constantly mindful and attentive to the balance of diet, exercise, and lifestyle in their day-to-day lives.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
JANUARY 9, 2024
Researchers attending gene therapy meetings over the past couple years were liable to bump into a svelte, graying scientist explaining in emphatic, Russian-inflected English that the U.S. was wasting the grand potential of CRISPR gene editing. Fyodor Urnov, the scientist in question, estimates he gave the talk 30 to 40 times: to fellow researchers, pharma executives, Food and Drug Administration officials, congressional staff, journalists, patient advocates.
Pharmacy Times
JANUARY 9, 2024
Berdazimer topical gel, 10.3% (Zelsuvmi; Ligand Pharmaceuticals Inc) has been approved for the treatment of molluscum contagiosum in individuals aged 1 year and older.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
JANUARY 9, 2024
On a sweltering day in August 2021, as the engines of a hulking C-17 cargo plane drowned out pops of gunfire and Taliban rocket explosions around them, the young Afghan couple looked down at their 4-month-old son, Mohammad, and felt a shuddering wave of relief. But as the plane lifted above the dusty peaks that hug Kabul like a fortress of sandstone and schist, that feeling grew heavy with grief — for the parents and siblings they were leaving behind, and for Afghanistan, the only home th
Fierce Pharma
JANUARY 9, 2024
Pfizer knows it had a bad year in 2023. Speaking to reporters at the 2024 J.P. | Pfizer knows it had a bad year in 2023. Speaking to reporters at the 2024 J.P. Morgan Healthcare Conference on Monday, the company’s CEO, Albert Bourla, spoke bluntly about the hits the company took, and he acknowledged the underperformance of certain key launches.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Drug Topics
JANUARY 9, 2024
In this conversation from the Healthcare Advocate Summit, Ned Woody, senior associate director of field reimbursement at Daiichi Sankyo Inc. - Oncology, discusses the disruptive impact that these programs have on patients.
STAT
JANUARY 9, 2024
SAN FRANCISCO — Peter Marks, the Food and Drug Administration’s top regulator of gene therapies, seems very comfortable with granting some form of full approval to Elevidys, the Sarepta Therapeutics gene therapy for Duchenne muscular dystrophy, based on his comments to me on Monday night during our “fireside chat” at a STAT event.
Drug Topics
JANUARY 9, 2024
Tyler Woods, PharmD, was joined by Ajay Mehra, chief financial officer and cofounder of UGO Rx, and Scott Cady, PharmD, during the Total Pharmacy Solutions Summit Fall 2023 to discuss how pharmacists can maximize opportunities to improve their stores.
STAT
JANUARY 9, 2024
Few public health challenges have been more daunting and persistent than the opioid crisis, which started because of egregious conduct by opioid manufacturers and now is driven by an influx of fentanyl. In my home state of New Hampshire — which has been at the forefront of this heartbreaking epidemic for more than a decade — too many promising futures have been snatched away.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Fierce Healthcare
JANUARY 9, 2024
Last August, Blue Shield of California made headlines when it rev | As the market shifts toward greater transparency, Express Scripts has rolled out multiple programs in the past year that aim to address some of the central criticisms of the industry.
STAT
JANUARY 9, 2024
SAN FRANCISCO — Six months into his tenure as CEO of cancer startup FogPharma, Mathai Mammen is taking the stage at the Westin St. Francis Tuesday for what he’s calling a “big unveil” of how he’s reshaping the biotech. And he’s prepared to go against the grain. Perhaps the most important thing he’s telling investors at the J.P.
Pharmacy Times
JANUARY 9, 2024
The accepted sBLA comes after phase 3 clinical trial results which demonstrated better overall survival, progression-free survival, and confirmed overall response rate than chemotherapy in patients with cervical cancer.
pharmaphorum
JANUARY 9, 2024
Discover how the UK Biobank is leveraging technology and the power of genomics in data-driven disease research. Join the digital revolution in understanding and combating diseases using cutting-edge techniques and large-scale genomic data analysis.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmacy Times
JANUARY 9, 2024
Anaïs Webster Mennuti, PharmD and Kristin Speer, PharmD, BCPS, discuss their new documentary that highlights the understaffed and overwhelmed reality of retail pharmacy.
STAT
JANUARY 9, 2024
SAN FRANCISCO — Almost three years ago, the country’s biggest bank unveiled a lofty plan to fix the health care industry’s entrenched problems. It broke off $250 million to stand up a new business unit, Morgan Health, to do so. Today, Morgan Health’s CEO, Dan Mendelson, aided by a newly hired flack, emailed reporters attending that bank’s annual investor confab, the J.P.
European Pharmaceutical Review
JANUARY 9, 2024
Revolutionising quality control In the backdrop of stringent quality standards and regulatory demands inherent to pharmaceutical manufacturing, the addition of AI technologies introduce a paradigm shift. This article highlights the manifold applications of AI, particularly cutting-edge image recognition and computer vision systems, which profoundly impact quality control.
Pharmacy Times
JANUARY 9, 2024
Patients who received telemedicine alone had worse glycemic control and less improvement in hemoglobin A1c levels.
pharmaphorum
JANUARY 9, 2024
In a new episode of the pharmaphorum podcast, host Nicole Raleigh speaks with Aman Wasan, CEO of ArisGlobal, about the digitisation of drug research and development, including using automation to analyse large datasets to identify new drug development opportunities, with patient safety ever at the forefront of such innovations.
Fierce Healthcare
JANUARY 9, 2024
Pharmacological interventions demonstrate fewer disparities in obesity treatment than behavioral and surgical treatment, a new literature review has found. | While most behavioral and surgical treatment studies reveal disparities in weight loss and clinical outcomes, pharmacological studies reveal minimal to no evidence of disparities and favorable outcomes for minorities.
Fierce Pharma
JANUARY 9, 2024
Two successful phase 3 trials put Astellas’ monoclonal antibody zolbetuximab on track to become the first approved therapy to treat one of the hottest targets in oncology—tumors that are claudin (C | Two successful phase 3 trials put Astellas’ monoclonal antibody zolbetuximab on track to become the first approved therapy to treat one of the hottest targets in oncology—tumors that are claudin (CLDN) positive.
PharmExec
JANUARY 9, 2024
Merck has acquired Harpoon Therapeutics with its clinical stage T-cell engager, whereas Johnson & Johnson acquired Ambrx Biopharma with its expertise in next generation antibody drug conjugates and targeted oncologic therapies.
pharmaphorum
JANUARY 9, 2024
Manufacturing problems have scuppered Astellas’ chances of approval in the US this month for zolbetuximab, currently leading the field among Claudin 18.2-targeted drug candidates for cancer.
Drug Store News
JANUARY 9, 2024
The personal care collection, which features deodorant, deodorant and body spray, body wash, shampoo and conditioner, is inspired by the cookies, the brand noted.
The Checkup by Singlecare
JANUARY 9, 2024
Taking saw palmetto can be beneficial for women of all ages. The historical use of saw palmetto includes regulating reproductive conditions, relieving cough , and increasing libido and sperm count in men. But this natural medicine can now be used for so much more. Dr. Kirby , a Nurse Practitioner at Health and Wellness Made Easy, says, “We usually think of saw palmetto for men and prostates, but this supplement can benefit women too.
pharmaphorum
JANUARY 9, 2024
Discover how AI innovations are revolutionising the engagement between life sciences companies and healthcare professionals. Learn about the latest advancements and their impact on the industry.
Drug Topics
JANUARY 9, 2024
Placing telepharmacy at the forefront of outdated workflows could transform the traditional pharmacy setting.
Fierce Healthcare
JANUARY 9, 2024
Walgreens has agreed to a $360 million settlement in arbitration dispute with Humana, the company disclosed late last week. | Walgreens has agreed to a $360 million settlement in arbitration dispute with Humana, the company disclosed late last week.
The Checkup by Singlecare
JANUARY 9, 2024
What is sea moss? Sea moss, also known as Chondrus Crispus or Irish moss, is a type of red seaweed. Sea moss can be harvested year-round from inlets and tidal pools off the coast of North America, the British Isles, and Europe. Cleaned of sand and debris, the edible sea plant is then prepared to make powder or gel that can be used as supplements, food additives, or cosmetic products.
Fierce Pharma
JANUARY 9, 2024
After Roche went through a period of declining sales in hematology—as powerhouse Rituxan faced biosimilar competition and follow-on Gazyva failed to live up to its blockbuster expectations—the comp | After Roche went through a period of declining sales in hematology—as powerhouse Rituxan faced biosimilar competition and follow-on Gazyva failed to live up to its blockbuster expectations—the company is rebounding quickly in blood cancer.
The Checkup by Singlecare
JANUARY 9, 2024
Nausea is an uneasiness in the stomach or an uncomfortable feeling in the back of the throat. Other symptoms like dizziness, lightheadedness, and trouble swallowing may accompany it. When you are experiencing symptoms of nausea, you may also vomit (throw up)—but nausea does not always lead to vomiting. Nausea may be associated with various illnesses, conditions, or treatments, such as: Cancer treatment (radiation or chemotherapy -induced nausea) Pregnancy (pregnant women may experience nausea an
Drug Store News
JANUARY 9, 2024
NACDS' new TV ad says the âclock is tickingâ for vital Medicare and Medicaid reforms needed to protect Americans, communities and pharmacies.
Fierce Healthcare
JANUARY 9, 2024
Centers for Medicare & Medicaid Services approved New York's amended Medicaid section 1115 demonstration on Tuesday, spurring the agency to invest in behavioral health and health equity initiat | CMS is helping revamp Medicaid in New York, including more than $3 billion in investments for high-risk social needs services.
Drug Store News
JANUARY 9, 2024
Cline will be featured as the face of the Revlon brand and products and across a marketing mix that includes in-store displays at retailer events and global campaigns.
Expert insights. Personalized for you.
138 
Let's personalize your content